CEMR:XETRA:XETRA-iShares Edge MSCI Europe Momentum Factor UCITS ETF EUR (Acc) (EUR)

ETF | Others |

Last Closing

USD 10.852

Change

0.00 (0.00)%

Market Cap

USD 0.33B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.04 (+0.07%)

USD 473.61B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.01 (+0.05%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.01 (-0.04%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.01 (-0.02%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.07 (-0.27%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-1.00 (-0.60%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

-0.05 (-0.10%)

USD 105.55B
8R80:XETRA Amundi Index Solutions - Amund..

-0.36 (-0.25%)

USD 99.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.09 (+0.17%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.72 (+0.33%)

USD 80.38B

ETFs Containing CEMR:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.70% 90% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.70% 90% A- 87% B+
Trailing 12 Months  
Capital Gain 16.96% 69% C- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.96% 69% C- 70% C-
Trailing 5 Years  
Capital Gain 65.60% 84% B 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 65.60% 84% B 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 8.97% 73% C 70% C-
Dividend Return 8.97% 72% C 68% D+
Total Return N/A 8% B- 15% F
Risk Return Profile  
Volatility (Standard Deviation) 13.34% 49% F 58% F
Risk Adjusted Return 67.27% 86% B+ 86% B+
Market Capitalization 0.33B 59% D- 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.